Eurobio Scientific SA (ALERS) — Working Capital to Net Assets Ratio
Eurobio Scientific SA (ALERS) has a Working Capital to Net Assets ratio of 33.6% as of June 2025. Working capital of €60.76 Million (current assets of €96.87 Million minus current liabilities of €36.12 Million) is measured against net assets of €180.85 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Eurobio Scientific SA (ALERS) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Eurobio Scientific SA Working Capital to Net Assets (2007–2024)
This chart shows how Eurobio Scientific SA's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2007 to 2024. As of June 2025, the ratio stands at 33.6%, reflecting working capital of €60.76 Million against net assets of €180.85 Million EUR. Check ALERS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Eurobio Scientific SA (2007–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Eurobio Scientific SA from 2007 to 2024, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Eurobio Scientific SA (ALERS) market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 25.4% | €45.44 Million | €178.85 Million | €89.59 Million | €44.15 Million | ▼ -26.6 pp |
| 2023 | 52.0% | €91.03 Million | €175.17 Million | €143.91 Million | €52.88 Million | ▼ -0.8 pp |
| 2022 | 52.7% | €91.06 Million | €172.67 Million | €148.37 Million | €57.32 Million | ▼ -32.7 pp |
| 2021 | 85.4% | €136.85 Million | €160.22 Million | €172.95 Million | €36.11 Million | ▲ +4.5 pp |
| 2020 | 80.9% | €87.23 Million | €107.84 Million | €135.21 Million | €47.98 Million | ▲ +57.6 pp |
| 2019 | 23.3% | €8.52 Million | €36.56 Million | €40.32 Million | €31.80 Million | ▼ -3.9 pp |
| 2018 | 27.3% | €8.07 Million | €29.62 Million | €31.84 Million | €23.77 Million | ▲ +8.9 pp |
| 2017 | 18.4% | €5.83 Million | €31.69 Million | €30.58 Million | €24.75 Million | ▼ -1.4 pp |
| 2016 | 19.8% | €2.42 Million | €12.23 Million | €18.69 Million | €16.27 Million | ▼ -28.5 pp |
| 2015 | 48.3% | €11.25 Million | €23.31 Million | €21.41 Million | €10.16 Million | ▼ -3.0 pp |
| 2014 | 51.3% | €14.34 Million | €27.95 Million | €24.22 Million | €9.89 Million | ▲ +24.9 pp |
| 2013 | 26.4% | €5.42 Million | €20.56 Million | €15.95 Million | €10.53 Million | ▼ -6.6 pp |
| 2012 | 33.0% | €8.08 Million | €24.50 Million | €19.38 Million | €11.30 Million | ▼ -64.0 pp |
| 2011 | 97.0% | €13.16 Million | €13.57 Million | €16.56 Million | €3.40 Million | ▼ -35.8 pp |
| 2010 | 132.8% | €25.49 Million | €19.19 Million | €29.49 Million | €4.00 Million | ▲ +14.1 pp |
| 2009 | 118.7% | €30.22 Million | €25.46 Million | €34.24 Million | €4.02 Million | ▼ -98.1 pp |
| 2008 | 216.8% | €21.11 Million | €9.74 Million | €26.80 Million | €5.69 Million | ▲ +57.9 pp |
| 2007 | 158.9% | €28.70 Million | €18.07 Million | €33.91 Million | €5.21 Million | — |